您当前的位置:

Propranolol HCl

(Synonyms: 盐酸普萘洛尔)
目录号: PC10707 纯度: ≥98%
竞争性和非选择性β-肾上腺素能受体抑制剂,Propranolol hydrochloride是一种非选择性β-肾上腺素能受体(βAR)拮抗剂, IC50 值为12 nM。
CAS No. :318-98-9
商品编号 规格 价格 会员价 是否有货 数量
PC10707-100mg 100mg ¥598.00 请登录
PC10707-500mg 500mg ¥853.00 请登录
PC10707-10mM (in 1mL DMSO) 10mM (in 1mL DMSO) ¥637.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Propranolol HCl
中文别名
心得安;萘心安;异丙基氨基-1-萘甲氧基-丙醇盐酸盐;盐酸普奈洛尔(心得安);1-异丙氨基-3-(1-萘氧基)-2-丙醇盐酸盐;盐酸普萘洛尔;(±)-盐酸普萘洛尔;盐酸普奈洛尔;(±)- 盐酸普萘洛尔标准品;DL-盐酸普萘洛尔;甲醇中心得安(普萘洛尔)溶液标准物质;消旋山莨菪碱;心得安,盐酸普萘洛尔[仅供出口];盐酸普奈洛尔 标准品;盐酸普奈洛尔、盐酸普萘洛尔;盐酸普萘洛尔 EP标准品;盐酸普萘洛尔 USP标准品;盐酸普萘洛尔 标准品;盐酸普萘洛尔,心得安;盐酸普萘洛尔性能测试 EP标准品;盐酸盐普萘洛尔 标准品;心得安(普萘洛尔,Propranolol)盐酸盐 标准品;盐酸普萘洛尔 1-异丙氨基-3-(1-萘氧基)-2-丙醇盐酸盐 心得安;盐酸普萘洛尔,(±)-Propranolol hydrochloride;盐酸普莱洛尔;心得安,医药级,纯度:>99%;盐酸普萘若尔
英文名称
Propranolol HCl
英文别名
Propranolol Hydrochloride;(RS)-1-[(1-METHYLETHYL)AMINO]-3-(1-NAPHTHALENYLOXY)-2-PROPANOL HYDROCHLORIDE;PROPRANOLOL HCL;(+/-)-PROPRANOLOL HYDROCHLORIDE;(+/-)-PROPANOLOL HCL;PROPANOLOL HYDROCHLORIDE;1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanohydrochloride;1-(1-naphthyloxy)-2-hydroxy-3-isopropylaminopropanehydrochloride;(±)-Propranolol hydrochloride;1-(Isopropylamino)-3-(a-naphthoxy)-2-propanolhydrochloride;DL-Propranolol hydrochloride;Propranolol (hydrochloride);Propranolol hydrochloride solution;Propranolol hydrochloride(Ciplar®, Inderal®, Deralin®,Avlocardyl®);Propranolol Solution;rac-Propranolol Hydr;rac-Propranolol Hydrochloride;deralin;dociton;frekven;inderal;inderex;inderol;kemi;oposim;Propranolol;Propranolol hyd;tesnol;Propmnolol hydrochloride;(±)-1-Isopropylamino-3-(1-naphthyloxy)-2-propanol hydrochloride;DL-1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride
Cas No.
318-98-9
分子式
C16H21NO2.HCl
分子量
295.80
包装储存

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

详情描述
竞争性和非选择性β-肾上腺素能受体抑制剂,Propranolol hydrochloride是一种非选择性β-肾上腺素能受体(βAR)拮抗剂, IC50 值为12 nM。
生物活性

Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively. Propranolol hydrochloride inhibits [H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy.

性状

Solid

IC50 & Target[1][2]

β adrenergic receptor

 

体外研究(In Vitro)

Propranolol hydrochloride (10 M-10 M; 24 and 48 hours) increases the total ERK1/2 levels in a dose-dependent manner, and ERK1/2 activation is observed specifically at 10 M in HemSCs.
Propranolol hydrochloride (10 M-10 M; 24 and 48 hours) significant decreases cell proliferation at 10 M propranolol after 24 hours and 10 M propranolol after 48 hours in HemSCs.
Propranolol hydrochloride (50 μM-200 μM; 24 hours) increases Annexin V positivity and caspase-3 activation, rapidly induces HemSC apoptosis.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis

Cell Line: HemSC cells
Concentration: 10 M-10 M
Incubation Time: 24 and 48 hours
Result: Increased the total ERK1/2 levels in a dose-dependent manner.

Cell Viability Assay

Cell Line: HemSC cells
Concentration: 10 M-10 M
Incubation Time: 24 and 48 hours
Result: Suppressed HemSC Proliferation.

Apoptosis Analysis

Cell Line: HemSC cells
Concentration: 50 μM, 100 μM, or 200 μM
Incubation Time: 24 hours
Result: Induced HemSC cell death occurred via an apoptotic pathway.
体内研究(In Vivo)

Propranolol hydrochloride (orally administration; 40 mg/kg; daily) significantly reduces the vessel diameter relative to the vehicle-treated implants, and increases the number of cells that expressed phosphorylated ERK1/2 within the IH Matrigel implant.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: A xenograft mouse model of IH (infantile hemangiomas) with HemSC cells
Dosage: 40 mg/kg
Administration: Orally administration; 40 mg/kg; daily
Result: Improved vessel development in the IH mouse model that correlated with MAPK pathway activation.
运输条件

Room temperature or refrigerated transportation.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

ClinicalTrial
结构分类
参考文献
溶解度数据
体外研究: 

DMSO : ≥ 150 mg/mL (507.10 mM)

H2O : 33.33 mg/mL (112.68 mM; Need ultrasonic)

* "≥" means soluble, but saturation unknown.

配制储备溶液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.3807 mL 16.9033 mL 33.8066 mL
5 mM 0.6761 mL 3.3807 mL 6.7613 mL
10 mM 0.3381 mL 1.6903 mL 3.3807 mL
*

产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,建议在 6 个月内使用,-20°C 储存时,建议在 1 个月内使用。

体内研究:

建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    建议依照次序添加每种溶剂: PBS

    Solubility: 25 mg/mL (84.52 mM); Clear solution; Need ultrasonic

*
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2